JP2010535252A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010535252A5 JP2010535252A5 JP2010520219A JP2010520219A JP2010535252A5 JP 2010535252 A5 JP2010535252 A5 JP 2010535252A5 JP 2010520219 A JP2010520219 A JP 2010520219A JP 2010520219 A JP2010520219 A JP 2010520219A JP 2010535252 A5 JP2010535252 A5 JP 2010535252A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- diabetes
- type
- metabolic
- nachr agonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95361407P | 2007-08-02 | 2007-08-02 | |
| US95361007P | 2007-08-02 | 2007-08-02 | |
| US95361307P | 2007-08-02 | 2007-08-02 | |
| US97165407P | 2007-09-12 | 2007-09-12 | |
| PCT/US2008/071893 WO2009018511A2 (en) | 2007-08-02 | 2008-08-01 | Alpha7 nachr agonists for treating or preventing metabolic disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010535252A JP2010535252A (ja) | 2010-11-18 |
| JP2010535252A5 true JP2010535252A5 (https=) | 2011-01-06 |
Family
ID=39945177
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010520219A Pending JP2010535252A (ja) | 2007-08-02 | 2008-08-01 | 代謝障害を治療または予防するためのα７ｎＡＣｈＲアゴニスト |
| JP2010520213A Active JP5358573B2 (ja) | 2007-08-02 | 2008-08-01 | （２ｓ，３ｒ）−ｎ−（２−（（３−ピリジニル）メチル）−１−アザビシクロ［２．２．２］オクタ−３−イル）ベンゾフラン−２−カルボキサミド、その新規塩形態およびその使用方法 |
| JP2013148087A Active JP5852611B2 (ja) | 2007-08-02 | 2013-07-17 | （２ｓ，３ｒ）−ｎ−（２−（（３−ピリジニル）メチル）−１−アザビシクロ［２．２．２］オクタ−３−イル）ベンゾフラン−２−カルボキサミド、その新規塩形態およびその使用方法 |
| JP2013148091A Active JP6106549B2 (ja) | 2007-08-02 | 2013-07-17 | （２ｓ，３ｒ）−ｎ−（２−（（３−ピリジニル）メチル）−１−アザビシクロ［２．２．２］オクタ−３−イル）ベンゾフラン−２−カルボキサミド、その新規塩形態およびその使用方法 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010520213A Active JP5358573B2 (ja) | 2007-08-02 | 2008-08-01 | （２ｓ，３ｒ）−ｎ−（２−（（３−ピリジニル）メチル）−１−アザビシクロ［２．２．２］オクタ−３−イル）ベンゾフラン−２−カルボキサミド、その新規塩形態およびその使用方法 |
| JP2013148087A Active JP5852611B2 (ja) | 2007-08-02 | 2013-07-17 | （２ｓ，３ｒ）−ｎ−（２−（（３−ピリジニル）メチル）−１−アザビシクロ［２．２．２］オクタ−３−イル）ベンゾフラン−２−カルボキサミド、その新規塩形態およびその使用方法 |
| JP2013148091A Active JP6106549B2 (ja) | 2007-08-02 | 2013-07-17 | （２ｓ，３ｒ）−ｎ−（２−（（３−ピリジニル）メチル）−１−アザビシクロ［２．２．２］オクタ−３−イル）ベンゾフラン−２−カルボキサミド、その新規塩形態およびその使用方法 |
Country Status (35)
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6953855B2 (en) * | 1998-12-11 | 2005-10-11 | Targacept, Inc. | 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| DE10164139A1 (de) | 2001-12-27 | 2003-07-10 | Bayer Ag | 2-Heteroarylcarbonsäureamide |
| US8314119B2 (en) * | 2006-11-06 | 2012-11-20 | Abbvie Inc. | Azaadamantane derivatives and methods of use |
| SA08290475B1 (ar) * | 2007-08-02 | 2013-06-22 | Targacept Inc | (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه |
| US20110098312A1 (en) * | 2008-05-12 | 2011-04-28 | Targacept ,Inc | Methods for preventing the development of retinopathy by the oral administration of nnr ligands |
| TW201031664A (en) | 2009-01-26 | 2010-09-01 | Targacept Inc | Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide |
| JO3250B1 (ar) | 2009-09-22 | 2018-09-16 | Novartis Ag | إستعمال منشطات مستقبل نيكوتينيك أسيتيل كولين ألفا 7 |
| PE20170923A1 (es) | 2010-05-17 | 2017-07-12 | Forum Pharmaceuticals Inc | Una forma cristalina de clorhidrato de (r)-7-cloro-n-(quinuclidin-3-il)benzo[b]tiofeno-2-carboxamida monohidratado |
| BR112013001939A2 (pt) * | 2010-07-26 | 2017-07-11 | Envivo Pharmaceuticals Inc | tratamento de distúrbios cognitivos com determinados agonistas receptores de ácido alfa-7-nicotínico em combinação com inibidres de acetilcolinesterase |
| PE20131394A1 (es) | 2010-09-23 | 2014-01-11 | Abbvie Inc | Monohidrato de derivados de aza-adamantano |
| CA2824900A1 (en) * | 2011-01-18 | 2012-07-26 | Targacept, Inc. | Treatment of cognitive dysfunction in schizophrenia |
| WO2012101060A1 (en) | 2011-01-27 | 2012-08-02 | Novartis Ag | Use of nicotinic acetylcholine receptor alpha 7 activators |
| HUE065359T2 (hu) | 2011-03-18 | 2024-05-28 | Alkermes Pharma Ireland Ltd | Szorbitán-észtereket tartalmazó gyógyászati készítmények |
| AU2012232711B2 (en) | 2011-03-18 | 2016-04-28 | Novartis Ag | Combinations of alpha 7 nicotinic acetylcholine receptor activators and mGluR5 antagonists for use in dopamine induced dyskinesia in Parkinson's Disease |
| WO2012129262A1 (en) * | 2011-03-23 | 2012-09-27 | Targacept, Inc. | Treatment of attention deficit/hyperactivity disease |
| BR112013032044A2 (pt) | 2011-06-30 | 2016-12-13 | Toray Industries | antiprurítico |
| TW201311698A (zh) * | 2011-08-22 | 2013-03-16 | Targacept Inc | 作為神經元菸鹼乙醯膽鹼受體配位體之１，４－二氮雜雙環［３．２．２］壬烷 |
| ES2776996T3 (es) | 2011-10-20 | 2020-08-03 | Novartis Ag | Biomarcadores predictivos de la sensibilidad al tratamiento por el activador del receptor de la acetilcolina nicotínico alfa 7 |
| ES2950418T3 (es) | 2012-03-19 | 2023-10-09 | Alkermes Pharma Ireland Ltd | Composiciones farmacéuticas que comprenden alcohol bencílico |
| JP6219918B2 (ja) * | 2012-03-19 | 2017-10-25 | アルカームス ファーマ アイルランド リミテッド | グリセロールエステルを含む医薬組成物 |
| ES2765036T3 (es) | 2012-03-19 | 2020-06-05 | Alkermes Pharma Ireland Ltd | Composiciones farmacéuticas que comprenden esteres de ácidos grasos |
| EP3461481A1 (en) | 2012-05-08 | 2019-04-03 | Forum Pharmaceuticals Inc. | Methods of maintaining, treating or improving cognitive function |
| EP2897592B1 (en) | 2012-09-19 | 2020-02-19 | Alkermes Pharma Ireland Limited | Pharmaceutical compositions having improved storage stability |
| CN104837499B (zh) | 2012-12-11 | 2018-02-23 | 诺华有限公司 | 预测对α7烟碱型乙酰胆碱受体激活剂治疗响应性的生物标志物 |
| MX362819B (es) * | 2013-01-15 | 2019-02-18 | Novartis Ag | Uso de agonistas del receptor nicotinico de acetilcolina alfa 7 para el tratamiento de la narcolepsia. |
| JP6338223B2 (ja) | 2013-01-15 | 2018-06-06 | ノバルティス アーゲー | アルファ７ニコチン性アセチルコリン受容体アゴニストの使用 |
| US20150313884A1 (en) | 2013-01-15 | 2015-11-05 | Novartis Ag | Use of alpha 7 nicotinic acetylcholine receptor agonists |
| KR101879919B1 (ko) | 2013-01-15 | 2018-07-18 | 노파르티스 아게 | 알파 7 니코틴성 아세틸콜린 수용체 작용물질의 용도 |
| WO2014153424A1 (en) * | 2013-03-19 | 2014-09-25 | La Jolla Institute For Allergy And Immunology | Reducing diabetes in patients receiving hmg-coa reductase inhibitors (statins) |
| BR112016021535A8 (pt) | 2014-03-20 | 2021-07-20 | Alkermes Pharma Ireland Ltd | kit compreendendo formulações de aripiprazol tendo velocidades de injeção aumentadas útil para o tratamento de uma desordem do sistema nervoso central e uso |
| SG11201608303QA (en) | 2014-04-04 | 2016-11-29 | Del Mar Pharmaceuticals | Use of dianhydrogalactitol and analogs or derivatives thereof to treat non-small-cell carcinoma of the lung and ovarian cancer |
| CN104288771B (zh) * | 2014-09-30 | 2017-03-15 | 郑州大学第五附属医院 | α7nAChR激动剂的新用途 |
| AU2016258192B2 (en) | 2015-05-06 | 2021-07-29 | Leidos Biomedical Research, Inc. | K-Ras modulators |
| US9724340B2 (en) * | 2015-07-31 | 2017-08-08 | Attenua, Inc. | Antitussive compositions and methods |
| US10282666B1 (en) | 2015-11-10 | 2019-05-07 | Google Llc | Coherency detection and information management system |
| RU2675111C2 (ru) * | 2017-03-31 | 2018-12-17 | Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фундаментальной и клинической иммунологии" | Способ стимуляции нейрогенеза в гиппокампе |
| EP3612526A2 (en) | 2017-04-20 | 2020-02-26 | The Regents of the University of California | K-ras modulators |
| EP3761983A1 (en) | 2018-03-05 | 2021-01-13 | Alkermes Pharma Ireland Limited | Aripiprazole dosing strategy |
Family Cites Families (108)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4203990A (en) | 1979-04-30 | 1980-05-20 | G. D. Searle & Co. | Anti-diarrheal 2-substituted quinuclidines |
| EP0353189B1 (de) | 1988-07-28 | 1994-01-12 | Ciba-Geigy Ag | Kupfer- und Nickeldihalogenidkomplexe, Verfahren zu deren Herstellung und deren Verwendung |
| US4922901A (en) | 1988-09-08 | 1990-05-08 | R. J. Reynolds Tobacco Company | Drug delivery articles utilizing electrical energy |
| EP0402056A3 (en) | 1989-06-06 | 1991-09-04 | Beecham Group p.l.c. | Azabicyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| EP0412798A3 (en) | 1989-08-08 | 1992-07-01 | Merck Sharp & Dohme Ltd. | Substituted pyridines, their preparation, formulations and use in dementia |
| IN173570B (https=) | 1989-11-23 | 1994-06-04 | Pfizer | |
| DK40890D0 (da) | 1990-02-16 | 1990-02-16 | Ferrosan As | Substituerede urinstofforbindelser, deres fremstilling og anvendelse |
| EP0492903A1 (en) | 1990-12-21 | 1992-07-01 | MERCK SHARP & DOHME LTD. | Substituted pyrazines, pyrimidines and pyridazines for use in the treatment of glaucoma |
| EP0573568B1 (en) | 1991-03-01 | 2001-01-24 | University Of Florida Research Foundation, Inc. | Use of nicotinic analogs for treatment of degenerative diseases of the nervous system |
| US5212188A (en) | 1992-03-02 | 1993-05-18 | R. J. Reynolds Tabacco Company | Method for treatment of neurodegenerative diseases |
| US5276043A (en) | 1992-04-10 | 1994-01-04 | R. J. Reynolds Tobacco Company | Method for treatment of neurodegenerative diseases |
| KR100272614B1 (ko) * | 1992-08-31 | 2000-11-15 | 엠. 잭 오해니언 | 신경계의 퇴행성 질환의 치료에 유용한 아나바세인 유도체 |
| US5977144A (en) | 1992-08-31 | 1999-11-02 | University Of Florida | Methods of use and compositions for benzylidene- and cinnamylidene-anabaseines |
| IL107184A (en) | 1992-10-09 | 1997-08-14 | Abbott Lab | Heterocyclic ether compounds that enhance cognitive function |
| US5852041A (en) | 1993-04-07 | 1998-12-22 | Sibia Neurosciences, Inc. | Substituted pyridines useful as modulators of acethylcholine receptors |
| IL109451A0 (en) * | 1993-04-29 | 1994-07-31 | Zeneca Ltd | Heterocyclic derivatives |
| AU7474794A (en) | 1993-07-22 | 1995-02-20 | E.I. Du Pont De Nemours And Company | Arthropodicidal azacyclic heterocycles |
| US5493026A (en) | 1993-10-25 | 1996-02-20 | Organix, Inc. | Substituted 2-carboxyalkyl-3-(fluorophenyl)-8-(3-halopropen-2-yl) nortropanes and their use as imaging for agents for neurodegenerative disorders |
| US5510355A (en) | 1994-09-06 | 1996-04-23 | Bencherif; Merouane | Depolarizing skeletal muscle relaxants |
| US5998404A (en) | 1994-10-24 | 1999-12-07 | Eli Lilly And Company | Heterocyclic compounds and their use |
| US5616707A (en) | 1995-01-06 | 1997-04-01 | Crooks; Peter A. | Compounds which are useful for prevention and treatment of central nervous system disorders |
| US5604231A (en) | 1995-01-06 | 1997-02-18 | Smith; Carr J. | Pharmaceutical compositions for prevention and treatment of ulcerative colitis |
| US5597919A (en) | 1995-01-06 | 1997-01-28 | Dull; Gary M. | Pyrimidinyl or Pyridinyl alkenyl amine compounds |
| US5824692A (en) | 1995-01-06 | 1998-10-20 | Lippiello; Patrick Michael | Pharmaceutical compositions for prevention and treatment of central nervous system disorders |
| JPH11500113A (ja) | 1995-02-17 | 1999-01-06 | ノボ ノルディスク アクティーゼルスカブ | ヘテロ環化合物類の使用 |
| US5585388A (en) | 1995-04-07 | 1996-12-17 | Sibia Neurosciences, Inc. | Substituted pyridines useful as modulators of acetylcholine receptors |
| US5583140A (en) | 1995-05-17 | 1996-12-10 | Bencherif; Merouane | Pharmaceutical compositions for the treatment of central nervous system disorders |
| IL118279A (en) | 1995-06-07 | 2006-10-05 | Abbott Lab | Compounds 3 - Pyridyloxy (or Thio) Alkyl Heterocyclic Pharmaceutical Compositions Containing Them and Their Uses for Preparing Drugs to Control Synaptic Chemical Transmission |
| WO1997001556A1 (en) | 1995-06-29 | 1997-01-16 | Novo Nordisk A/S | Novel substituted azacyclic or azabicyclic compounds |
| JPH11512443A (ja) | 1995-09-22 | 1999-10-26 | ノボ ノルディスク アクティーゼルスカブ | 新規な置換アザ環式またはアザ二環式化合物 |
| US5712270A (en) | 1995-11-06 | 1998-01-27 | American Home Products Corporation | 2-arylamidothiazole derivatives with CNS activity |
| US5616716A (en) | 1996-01-06 | 1997-04-01 | Dull; Gary M. | (3-(5-ethoxypyridin)yl)-alkenyl 1 amine compounds |
| SE9600683D0 (sv) | 1996-02-23 | 1996-02-23 | Astra Ab | Azabicyclic esters of carbamic acids useful in therapy |
| US5663356A (en) | 1996-04-23 | 1997-09-02 | Ruecroft; Graham | Method for preparation of aryl substituted alefinic secondary amino compounds |
| US5726189A (en) | 1996-05-03 | 1998-03-10 | The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Method for imaging nicotinic acetylcholinergic receptors in the brain using radiolabeled pyridyl-7-azabicyclo 2.2.1!heptanes |
| ZA9711092B (en) | 1996-12-11 | 1999-07-22 | Smithkline Beecham Corp | Novel compounds. |
| US5811442A (en) | 1997-02-21 | 1998-09-22 | Bencherif; Merouane | Pharmaceutical compositions for the treatment of conditions associated with decreased blood flow |
| US5861423A (en) | 1997-02-21 | 1999-01-19 | Caldwell; William Scott | Pharmaceutical compositions incorporating aryl substituted olefinic amine compounds |
| KR100589872B1 (ko) | 1997-05-30 | 2006-06-15 | 뉴로서치 에이/에스 | 8-아자비사이클로(3,2,1)옥트-2-엔 유도체 및 이의 제조방법 |
| AR013184A1 (es) * | 1997-07-18 | 2000-12-13 | Astrazeneca Ab | Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis |
| US5952339A (en) | 1998-04-02 | 1999-09-14 | Bencherif; Merouane | Pharmaceutical compositions and methods of using nicotinic antagonists for treating a condition or disorder characterized by alteration in normal neurotransmitter release |
| WO1999051602A1 (en) | 1998-04-02 | 1999-10-14 | R.J. Reynolds Tobacco Company | Azatricyclo[3.3.1.1] decane derivatives and pharmaceutical compositions containing them |
| DK1083889T3 (da) | 1998-06-01 | 2004-04-13 | Ortho Mcneil Pharm Inc | Tetrahydronaphthalenforbindelser og deres anvendelse til behandling af neurodegenerative sygdomme |
| US6310043B1 (en) | 1998-08-07 | 2001-10-30 | Governors Of The University Of Alberta | Treatment of bacterial infections |
| GB9821503D0 (en) | 1998-10-02 | 1998-11-25 | Novartis Ag | Organic compounds |
| US6432975B1 (en) | 1998-12-11 | 2002-08-13 | Targacept, Inc. | Pharmaceutical compositions and methods for use |
| US6953855B2 (en) * | 1998-12-11 | 2005-10-11 | Targacept, Inc. | 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| US6734215B2 (en) | 1998-12-16 | 2004-05-11 | University Of South Florida | Exo-S-mecamylamine formulation and use in treatment |
| SE9900100D0 (sv) * | 1999-01-15 | 1999-01-15 | Astra Ab | New compounds |
| FR2791678B1 (fr) * | 1999-03-30 | 2001-05-04 | Synthelabo | Derives de 1,4-diazabicyclo [3.2.2] nonane-4-carboxylates et -carboxamides, leur preparation et leur application en therapeutique |
| SE9904176D0 (sv) | 1999-11-18 | 1999-11-18 | Astra Ab | New use |
| SE0000540D0 (sv) | 2000-02-18 | 2000-02-18 | Astrazeneca Ab | New compounds |
| GB0010955D0 (en) | 2000-05-05 | 2000-06-28 | Novartis Ag | Organic compounds |
| KR100751981B1 (ko) | 2000-06-27 | 2007-08-28 | 라보라토리오스 살바트, 에스.에이. | 아릴알킬아민으로부터 유도된 카바메이트 |
| AU2001284645A1 (en) | 2000-08-18 | 2002-03-04 | Pharmacia And Upjohn Company | Quinuclidine-substituted aryl compounds for treatment of disease |
| US6479510B2 (en) | 2000-08-18 | 2002-11-12 | Pharmacia & Upjohn Company | Quinuclidine-substituted aryl compounds for treatment of disease |
| WO2002016357A2 (en) | 2000-08-18 | 2002-02-28 | Pharmacia & Upjohn Company | Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands) |
| WO2002016355A2 (en) | 2000-08-21 | 2002-02-28 | Pharmacia & Upjohn Company | Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic) acetylcholine receptor ligands |
| US6599916B2 (en) | 2000-08-21 | 2003-07-29 | Pharmacia & Upjohn Company | Quinuclidine-substituted heteroaryl moieties for treatment of disease |
| AU2001282875A1 (en) | 2000-08-21 | 2002-03-04 | Pharmacia And Upjohn Company | Quinuclidine-substituted heteroaryl moieties for treatment of disease |
| NZ526580A (en) | 2000-12-22 | 2005-04-29 | Almirall Prodesfarma Ag | Quinuclidine carbamate derivatives and their use as M3 antagonists |
| US20020086871A1 (en) * | 2000-12-29 | 2002-07-04 | O'neill Brian Thomas | Pharmaceutical composition for the treatment of CNS and other disorders |
| BR0210075A (pt) | 2001-06-01 | 2004-08-17 | Astrazeneca Ab | Composto, composição farmacêutica, uso de um composto, e, métodos de tratamento ou profilaxia de doenças ou condições humanas, de distúrbios psicóticos ou distúrbios da debilitação intelectual e de fadiga de vÈo, cessamento de fumar, dependência de nicotina, dores, e para a colite ulcerativa |
| US6569865B2 (en) | 2001-06-01 | 2003-05-27 | Astrazeneca Ab | Spiro 1-azabicyclo[2.2.2]octane-3,2′(3′h)-furo[2,3-b]pyridine |
| AR036040A1 (es) * | 2001-06-12 | 2004-08-04 | Upjohn Co | Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen |
| US7109204B2 (en) | 2001-08-01 | 2006-09-19 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
| CA2458375A1 (en) | 2001-08-24 | 2003-03-06 | Pharmacia & Upjohn Company | Substituted-heteroaryl-7-aza¬2.2.1|bicycloheptanes for the treatment of disease |
| JP2005504059A (ja) | 2001-08-24 | 2005-02-10 | ファルマシア アンド アップジョン カンパニー リミティド ライアビリティー カンパニー | 疾患を処置するための置換アリール７−アザ［２．２．１］ビシクロヘプタン |
| DE60218493D1 (de) | 2001-09-12 | 2007-04-12 | Pharmacia & Upjohn Co Llc | Substituierte 7-aza-ä2.2.1übicycloheptane für die behandlung von krankheiten |
| CA2476681A1 (en) | 2002-02-19 | 2003-08-28 | Bruce N. Rogers | Fused bicyclic-n-bridged-heteroaromatic carboxamides for the treatment of disease |
| WO2003072578A1 (en) | 2002-02-20 | 2003-09-04 | Pharmacia & Upjohn Company | Azabicyclic compounds with alfa7 nicotinic acetylcholine receptor activity |
| NZ561993A (en) | 2002-04-18 | 2008-09-26 | Astrazeneca Ab | Spiroazabicyclic heterocyclic amines as potent ligands for nicotinic acetylcholine receptors |
| ES2348282T3 (es) | 2002-04-18 | 2010-12-02 | Astrazeneca Ab | Compuestos de tienilo. |
| US7417049B2 (en) | 2002-04-18 | 2008-08-26 | Astrazeneca Ab | Furyl compounds |
| US7176198B2 (en) | 2002-08-01 | 2007-02-13 | Pfizer Inc. | 1H-pyrazole and 1H-pyrrole-azabicyclic compounds for the treatment of disease |
| WO2004016608A1 (en) | 2002-08-14 | 2004-02-26 | Neurosearch A/S | Novel quinuclidine derivatives and their use |
| SE0202465D0 (sv) | 2002-08-14 | 2002-08-14 | Astrazeneca Ab | New compounds |
| SE0202430D0 (sv) | 2002-08-14 | 2002-08-14 | Astrazeneca Ab | New Compounds |
| US7244745B2 (en) | 2002-08-30 | 2007-07-17 | Memory Pharmaceuticals Corp. | Heterocyclic compounds, methods for the preparation thereof, and uses thereof |
| MXPA05003317A (es) | 2002-09-25 | 2005-07-05 | Memory Pharm Corp | Indazoles, benzotiazoles y benzoisotiazoles asi como preparacion y usos de los mismos. |
| WO2004039815A2 (en) | 2002-11-01 | 2004-05-13 | Pharmacia & Upjohn Company Llc | Compounds having both alpha7 nachr agonist and 5ht antagonist activity for treatment of cns diseases |
| AU2003269413A1 (en) | 2002-11-01 | 2004-05-25 | Pharmacia & Upjohn Company Llc | Nicotinic acetylcholine agonists in the treatment of glaucoma and retinal neuropathy |
| JP4750421B2 (ja) | 2002-12-06 | 2011-08-17 | ノース ショア−ロング アイランド ジュ−イッシュ リサ−チ インスティチュ−ト | α７受容体結合コリン作動性アゴニストを用いる炎症の阻害 |
| AP2005003336A0 (en) | 2002-12-11 | 2005-06-30 | Pharmacia & Upjohn Co Llc | Combination for the treatment of ADHD |
| PL377777A1 (pl) | 2002-12-11 | 2006-02-20 | Pharmacia & Upjohn Company Llc | Leczenie chorób połączeniami agonistów receptora alfa 7-nikotynowego i innych związków |
| US6917746B2 (en) | 2002-12-17 | 2005-07-12 | 3M Innovative Properties Company | Apparatus and method for creating a fiber optic circuit |
| US6777617B2 (en) | 2002-12-30 | 2004-08-17 | 3M Innovative Properties Company | Telecommunications terminal |
| DE602004023586D1 (de) | 2003-02-27 | 2009-11-26 | Neurosearch As | Neue diazabicyclische arylderivate |
| CN1829721A (zh) | 2003-07-08 | 2006-09-06 | 阿斯利康(瑞典)有限公司 | 对α7烟碱乙酰胆碱受体具有亲和力的螺[1－氮杂二环[2.2.2]辛烷－3,5’－噁唑烷]－2’－酮衍生物 |
| AU2004276061A1 (en) | 2003-09-25 | 2005-04-07 | Astrazeneca Ab | Ligands |
| BRPI0415546A (pt) | 2003-10-21 | 2006-12-26 | Astrazeneca Ab | composto, composição farmacêutica, uso de um composto, e, métodos de tratamento ou profilaxia de doenças ou condições humanas, e de distúrbios |
| US20050137398A1 (en) | 2003-12-22 | 2005-06-23 | Jianguo Ji | 3-Quinuclidinyl heteroatom bridged biaryl derivatives |
| US20050137217A1 (en) | 2003-12-22 | 2005-06-23 | Jianguo Ji | Spirocyclic quinuclidinic ether derivatives |
| US7160876B2 (en) | 2003-12-22 | 2007-01-09 | Abbott Laboratories | Fused bicycloheterocycle substituted quinuclidine derivatives |
| US20050245531A1 (en) | 2003-12-22 | 2005-11-03 | Abbott Laboratories | Fused bicycloheterocycle substituted quinuclidine derivatives |
| US20050137203A1 (en) | 2003-12-22 | 2005-06-23 | Jianguo Ji | 3-quinuclidinyl amino-substituted biaryl derivatives |
| JP2007520527A (ja) * | 2004-02-04 | 2007-07-26 | ノイロサーチ アクティーゼルスカブ | ニコチン性アセチルコリン受容体リガンドとしてのジアザ２環式アリール誘導体 |
| CA2567977A1 (en) | 2004-04-22 | 2006-01-05 | Memory Pharmaceutical Corporation | Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof |
| NZ551712A (en) | 2004-05-07 | 2010-07-30 | Memory Pharm Corp | 1H-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparations and uses thereof |
| ATE493415T1 (de) * | 2004-10-20 | 2011-01-15 | Neurosearch As | Neue diazabizyklische arylderivate und medizinische verwendung dafür |
| MX2007006743A (es) | 2004-12-15 | 2007-07-09 | Astrazeneca Ab | Ligandos del receptor de acetilcolina nicotinica. |
| CA2591817A1 (en) * | 2004-12-22 | 2006-06-29 | Memory Pharmaceuticals Corporation | Nicotinic alpha-7 receptor ligands and preparation and uses thereof |
| EP1891036A4 (en) | 2005-06-07 | 2010-08-04 | Univ Florida | SELECTIVE LIGANDS FOR ALPHA-7 NICOTINE RECEPTORS |
| US7732607B2 (en) | 2005-08-22 | 2010-06-08 | Anatoly Mazurov | Heteroaryl-substituted diazatricycloalkanes and methods of use thereof |
| CN101312968A (zh) | 2005-09-23 | 2008-11-26 | 记忆药物公司 | 吲唑、苯并噻唑、苯并异噻唑、苯并异噁唑、吡唑并吡啶、异噻唑并吡啶及其制备和用途 |
| US8316104B2 (en) * | 2005-11-15 | 2012-11-20 | California Institute Of Technology | Method and apparatus for collaborative system |
| SA08290475B1 (ar) * | 2007-08-02 | 2013-06-22 | Targacept Inc | (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه |
| KR20100113163A (ko) * | 2008-02-13 | 2010-10-20 | 타가셉트 인코포레이티드 | 알파 ７ 니코틴 작용제 및 항정신병제의 조합 |
-
2008
- 2008-07-03 SA SA08290475A patent/SA08290475B1/ar unknown
- 2008-07-31 TW TW102135271A patent/TW201402116A/zh unknown
- 2008-07-31 TW TW097129030A patent/TWI429435B/zh not_active IP Right Cessation
- 2008-07-31 TW TW102135272A patent/TW201402117A/zh unknown
- 2008-08-01 US US12/674,327 patent/US20110124678A1/en not_active Abandoned
- 2008-08-01 US US12/184,312 patent/US7981906B2/en active Active
- 2008-08-01 PE PE2008001292A patent/PE20090566A1/es not_active Application Discontinuation
- 2008-08-01 RS RS20130115A patent/RS52743B/sr unknown
- 2008-08-01 MX MX2012009257A patent/MX346451B/es unknown
- 2008-08-01 EP EP11194142.3A patent/EP2431037B1/en active Active
- 2008-08-01 NZ NZ582828A patent/NZ582828A/en not_active IP Right Cessation
- 2008-08-01 PE PE2012000921A patent/PE20121821A1/es not_active Application Discontinuation
- 2008-08-01 MX MX2010001293A patent/MX2010001293A/es not_active Application Discontinuation
- 2008-08-01 SI SI200830931T patent/SI2182949T1/sl unknown
- 2008-08-01 EP EP11194161.3A patent/EP2465501B1/en active Active
- 2008-08-01 CA CA2694510A patent/CA2694510A1/en not_active Abandoned
- 2008-08-01 JP JP2010520219A patent/JP2010535252A/ja active Pending
- 2008-08-01 CA CA2694504A patent/CA2694504C/en not_active Expired - Fee Related
- 2008-08-01 EP EP12164661A patent/EP2484363A1/en not_active Withdrawn
- 2008-08-01 AU AU2008283813A patent/AU2008283813A1/en not_active Abandoned
- 2008-08-01 EP EP08782589A patent/EP2185152A2/en not_active Withdrawn
- 2008-08-01 PL PL08782584T patent/PL2182949T3/pl unknown
- 2008-08-01 BR BRPI0814889A patent/BRPI0814889A2/pt not_active IP Right Cessation
- 2008-08-01 KR KR1020107004202A patent/KR20100063043A/ko not_active Withdrawn
- 2008-08-01 DK DK11194142.3T patent/DK2431037T3/en active
- 2008-08-01 CN CN200880101593A patent/CN101868237A/zh active Pending
- 2008-08-01 SA SA112330303A patent/SA112330303B1/ar unknown
- 2008-08-01 AR ARP080103348A patent/AR067775A1/es not_active Application Discontinuation
- 2008-08-01 HU HUE11194142A patent/HUE030387T2/en unknown
- 2008-08-01 KR KR1020107004216A patent/KR20100051684A/ko not_active Ceased
- 2008-08-01 CN CN200880103971.1A patent/CN101784273B/zh not_active Expired - Fee Related
- 2008-08-01 PE PE2012000920A patent/PE20121820A1/es not_active Application Discontinuation
- 2008-08-01 UY UY0001031265A patent/UY31265A/es not_active Application Discontinuation
- 2008-08-01 ES ES08782584T patent/ES2415107T3/es active Active
- 2008-08-01 EP EP11075209A patent/EP2409703A1/en not_active Withdrawn
- 2008-08-01 AU AU2008283807A patent/AU2008283807B2/en not_active Ceased
- 2008-08-01 CL CL2008002271A patent/CL2008002271A1/es unknown
- 2008-08-01 ME MEP-2013-28A patent/ME01508B/me unknown
- 2008-08-01 NZ NZ582986A patent/NZ582986A/en not_active IP Right Cessation
- 2008-08-01 WO PCT/US2008/071893 patent/WO2009018511A2/en not_active Ceased
- 2008-08-01 PT PT87825840T patent/PT2182949E/pt unknown
- 2008-08-01 ES ES11194161.3T patent/ES2606752T3/es active Active
- 2008-08-01 WO PCT/US2008/071872 patent/WO2009018505A1/en not_active Ceased
- 2008-08-01 PH PH1/2012/501514A patent/PH12012501514A1/en unknown
- 2008-08-01 PH PH1/2012/501513A patent/PH12012501513A1/en unknown
- 2008-08-01 JP JP2010520213A patent/JP5358573B2/ja active Active
- 2008-08-01 HR HRP20130286AT patent/HRP20130286T1/hr unknown
- 2008-08-01 CN CN2013100489009A patent/CN103172628A/zh active Pending
- 2008-08-01 CN CN201611140124.5A patent/CN106831755A/zh active Pending
- 2008-08-01 DK DK08782584.0T patent/DK2182949T3/da active
- 2008-08-01 ES ES11194142.3T patent/ES2611139T3/es active Active
- 2008-08-01 MX MX2012009258A patent/MX346748B/es unknown
- 2008-08-01 BR BRPI0815009-5A2A patent/BRPI0815009A2/pt not_active IP Right Cessation
- 2008-08-01 EP EP08782584A patent/EP2182949B1/en active Active
- 2008-08-01 MY MYPI2010000501A patent/MY148002A/en unknown
-
2010
- 2010-01-18 NO NO20100078A patent/NO20100078L/no not_active Application Discontinuation
- 2010-01-18 NO NO20100077A patent/NO20100077L/no not_active Application Discontinuation
- 2010-01-29 ZA ZA2010/00719A patent/ZA201000719B/en unknown
- 2010-03-02 CO CO10024587A patent/CO6260081A2/es not_active Application Discontinuation
- 2010-03-02 CO CO10024579A patent/CO6260080A2/es not_active Application Discontinuation
- 2010-03-02 EC EC2010010007A patent/ECSP10010007A/es unknown
- 2010-03-02 EC EC2010010008A patent/ECSP10010008A/es unknown
-
2011
- 2011-05-26 US US13/116,080 patent/US8541446B2/en active Active
- 2011-05-26 US US13/116,163 patent/US8119659B2/en active Active
-
2012
- 2012-04-02 IL IL218976A patent/IL218976A0/en not_active IP Right Cessation
- 2012-06-04 AU AU2012203288A patent/AU2012203288B2/en not_active Ceased
- 2012-09-19 RU RU2012140148/15A patent/RU2012140148A/ru not_active Application Discontinuation
- 2012-09-19 RU RU2012140182/15A patent/RU2012140182A/ru not_active Application Discontinuation
-
2013
- 2013-01-30 CY CY20131100081T patent/CY1113561T1/el unknown
- 2013-07-17 JP JP2013148087A patent/JP5852611B2/ja active Active
- 2013-07-17 JP JP2013148091A patent/JP6106549B2/ja active Active
- 2013-07-22 US US13/947,157 patent/US8846715B2/en active Active
- 2013-08-02 CL CL2013002227A patent/CL2013002227A1/es unknown
- 2013-08-02 CL CL2013002226A patent/CL2013002226A1/es unknown
-
2014
- 2014-08-25 US US14/467,289 patent/US20150045386A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010535252A5 (https=) | ||
| CN101534809B (zh) | 取代的2-氨基1,2,3,4-四氢化萘在制备预防、减轻和/或治疗各类疼痛的药物中的用途 | |
| JP2008007519A5 (https=) | ||
| FI3287124T3 (fi) | Ketamiinin oraalinen annosmuoto | |
| JP2007504174A5 (https=) | ||
| JP2009542702A5 (https=) | ||
| MX2010005342A (es) | Compuestos indola y metodos para tratar el dolor visceral. | |
| JP2009542699A5 (https=) | ||
| JP2013525444A5 (https=) | ||
| NZ593754A (en) | Dpp-iv inhibitors for treatment of diabetes in paediatric patients | |
| JP2011516417A5 (https=) | ||
| WO2011014255A8 (en) | Treatment of crohn's disease with laquinimod | |
| CN1440283A (zh) | 有机化合物的联合形式 | |
| RU2010143864A (ru) | Способы лечения нарушений с применением селективного антагониста nr2b-подтипа nmda рецепторов | |
| EP2283843A3 (en) | Opioids for the treatment of the chronic obstructive pulmonary disease (COPD) | |
| JP2019517542A5 (https=) | ||
| UA107578C2 (uk) | Комбінована терапія при лікуванні діабету | |
| PH12014502448A1 (en) | Pharmaceutical combinations for the treatment of metabolic disorders | |
| JP2008535785A5 (https=) | ||
| WO2007105113A3 (en) | Use of crf1 receptor antagonists for preparing a drug for treating metabolic syndrome and/or obesity and/or dyslipoproteinemia | |
| US20140045801A1 (en) | Pramipexole transdermal delivery for severe headaches | |
| JP2012531402A5 (https=) | ||
| JP2013536837A5 (https=) | ||
| RS51388B2 (sr) | Primena jedne kombinacije morfina i najmanje jednog opijat antagonista za tretman zavisnosti od opijata i za smanjenje neoralne zloupotrebe kod zavisnika od opijata | |
| JP2008538582A (ja) | 精神病性障害の治療または予防のための新規の治療的組み合わせ |